A role for the Rb family of proteins in controlling telomere length

被引:97
作者
García-Cao, M
Gonzalo, S
Dean, D
Blasco, MA [1 ]
机构
[1] Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain
[2] Washington Univ, Sch Med, Div Mol Oncol, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ng1011
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The molecular mechanisms of cellular mortality have recently begun to be unraveled. In particular, it has been discovered that cells that lack telomerase are subject to telomere attrition with each round of replication, eventually leading to loss of telomere capping function at chromosome ends(1-5). Critically short telomeres and telomeres lacking telomere-binding proteins lose their functionality and are metabolized as DNA breaks, thus generating chromosomal fusions(1-8). Telomerase activity is sufficient to rescue short telomeres and confers an unlimited proliferative capacity(9-11). In addition, the tumor-suppressor pathway Cdkn2a/Rb1 has also been implicated as a barrier to immortalization(12-14). Here, we report a connection between the members of the retinoblastoma family of proteins, Rb1 (retinoblastoma 1), Rbl1 (retinoblastoma-like 1) and Rbl2 (retinoblastoma-like 2), and the mechanisms that regulate telomere length. In particular, mouse embryonic fibroblasts doubly deficient in Rbl1 and Rbl2 or triply deficient in Rbl1, Rbl2 and Rb1 have markedly elongated telomeres compared with those of wildtype or Rb1-deficient cells. This deregulation of telomere length is not associated with increased telomerase activity. Notably, the abnormally elongated telomeres in doubly or triply deficient cells retain their end-capping function, as shown by the normal frequency of chromosomal fusions. These findings demonstrate a connection between the Rb1 family and the control of telomere length in mammalian cells.
引用
收藏
页码:415 / 419
页数:5
相关论文
共 29 条
  • [1] Switching and signaling at the telomere
    Blackburn, EH
    [J]. CELL, 2001, 106 (06) : 661 - 673
  • [2] Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
    Blasco, MA
    Lee, HW
    Hande, MP
    Samper, E
    Lansdorp, PM
    DePinho, RA
    Greider, CW
    [J]. CELL, 1997, 91 (01) : 25 - 34
  • [3] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [4] New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin
    Chan, SWL
    Blackburn, EH
    [J]. ONCOGENE, 2002, 21 (04) : 553 - 563
  • [5] A HUMAN TELOMERIC PROTEIN
    CHONG, L
    VANSTEENSEL, B
    BROCCOLI, D
    ERDJUMENTBROMAGE, H
    HANISH, J
    TEMPST, P
    DELANGE, T
    [J]. SCIENCE, 1995, 270 (5242) : 1663 - 1667
  • [6] Telomerase in the human organism
    Collins, K
    Mitchell, JR
    [J]. ONCOGENE, 2002, 21 (04) : 564 - 579
  • [7] Protection of mammalian telomeres
    de Lange, T
    [J]. ONCOGENE, 2002, 21 (04) : 532 - 540
  • [8] Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres
    Espejel, S
    Franco, S
    Rodríguez-Perales, S
    Bouffler, SD
    Cigudosa, JC
    Blasco, MA
    [J]. EMBO JOURNAL, 2002, 21 (09) : 2207 - 2219
  • [9] Genetic and epigenetic changes in human epithelial cells immortalized by telomerase
    Farwell, DG
    Shera, KA
    Koop, JI
    Bonnet, GA
    Matthews, CP
    Reuther, GW
    Coltrera, MD
    McDougall, JK
    Klingelhutz, AJ
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05) : 1537 - 1547
  • [10] Many ways to telomere dysfunction:: in vivo studies using mouse models
    Goytisolo, FA
    Blasco, MA
    [J]. ONCOGENE, 2002, 21 (04) : 584 - 591